{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:52:51Z","timestamp":1791175971579,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.schres.2006.07.012","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T11:55:59Z","timestamp":1157198159000},"page":"179-186","source":"Crossref","is-referenced-by-count":40,"title":["Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia \u2014 Findings from an in vivo SPECT study"],"prefix":"10.1016","volume":"88","author":[{"given":"Lakshmi N.P.","family":"Voruganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. George","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2006.07.012_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","article-title":"Subjective response to neuroleptic in schizophrenia","volume":"19","author":"Awad","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2006.07.012_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0278-5846(85)90021-1","article-title":"Early treatment events and prediction of response to neuroleptic in schizophrenia","volume":"9","author":"Awad","year":"1985","journal-title":"Prog. Neuro-psychopharmacol Biol. Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2006.07.012_bib34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200418130-00004","article-title":"Impact of novel antipsychotic drugs","volume":"18","author":"Awad","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2006.07.012_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1300\/J374v01n02_06","article-title":"Neuroleptic dysphoria, comorbid drug abuse in schizophrenia and the emerging science of subjective tolerability","volume":"1","author":"Awad","year":"2005","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.schres.2006.07.012_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00023210-199504010-00002","article-title":"The aim of antipsychotic medication: where are they and are they being achieved","volume":"4","author":"Awad","year":"1995","journal-title":"CNS Drugs"},{"issue":"Supple. 3","key":"10.1016\/j.schres.2006.07.012_bib5","first-page":"123","article-title":"Patient's subjective experiences on antipsychotic medications: implications for outcome and quality of life","volume":"10","author":"Awad","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2006.07.012_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1192\/bjp.131.2.222b","article-title":"Haloperidol in normals","volume":"131","author":"Bellmaker","year":"1977","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl. 427","key":"10.1016\/j.schres.2006.07.012_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.2005.00540.x","article-title":"The role of dopamine in reward and pleasure behaviour \u2014 review of data from pre-clinical studies","volume":"III","author":"Bressan","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2006.07.012_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","article-title":"A neurobiological basis for substance abuse comorbidity in schizophrenia","volume":"50","author":"Chambers","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2006.07.012_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.160.2.303","article-title":"Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study","volume":"160","author":"De Haan","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib11","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1176\/appi.ajp.162.9.1755","article-title":"Subjective experiences during dopamine depletion","volume":"162","author":"De Haan","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib12","first-page":"5","article-title":"History, evolution and diagnosis of premenstrual dysphoric disorder","volume":"61","author":"Endicott","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib13","series-title":"Handbook of Physiology: The Nervous System IV","first-page":"647","article-title":"Reward, Motivation, Cognition: Psychobiology of Mesotelencephalic Dopamine System","author":"Fibiger","year":"1986"},{"key":"10.1016\/j.schres.2006.07.012_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(99)00817-1","article-title":"Imaging extrastriatal dopamine D2 receptor occupancy by endogenous dopamine in healthy human","volume":"387","author":"Fujeta","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2006.07.012_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005053-196509000-00006","article-title":"Addiction Research Centre Inventory (ARCI): development of a general drug estimation scale","volume":"141","author":"Haertzen","year":"1965","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2006.07.012_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291700050182","article-title":"A self-report scale predictive of drug complaince in schzophrenics: reliability and discrimnate ability","volume":"13","author":"Hogan","year":"1983","journal-title":"Psychol. Med."},{"issue":"7","key":"10.1016\/j.schres.2006.07.012_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndromes Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2006.07.012_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(97)00043-2","article-title":"Imaging D2 receptor occupancy by endogenous dopamine in humans","volume":"17","author":"Laruelle","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"S6","key":"10.1016\/j.schres.2006.07.012_bib20","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/S0893-133X(99)00105-0","article-title":"Limitations of dopamine in D2 and the search for novel antipsychotic strategies","volume":"21","author":"Marder","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2006.07.012_bib21","series-title":"Manual for the Profile of Mood States","author":"McNair","year":"1992"},{"key":"10.1016\/j.schres.2006.07.012_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00690925","article-title":"Haloperidol-induced emotional defecation: possible model for neuroleptic anxiety syndrome","volume":"91","author":"Russell","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2006.07.012_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.schres.2006.07.012_bib24","first-page":"191","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance","volume":"37","author":"Singh","year":"1976","journal-title":"Dis. Ner. Syst."},{"key":"10.1016\/j.schres.2006.07.012_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archpsyc.1978.01770280087009","article-title":"Subjective response as a predictor of outcome in pharmacotherapy","volume":"35","author":"Van Putten","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archpsyc.1981.01780270073010","article-title":"Subjective response to antipsychotic drugs","volume":"38","author":"Van Putten","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2006.07.012_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0091-3057(02)01028-6","article-title":"Effects of catecholamine depletion on D2 receptor binding, motivation and attentiveness in humans: a replication study","volume":"74","author":"Verhoff","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2006.07.012_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-003-1648-y","article-title":"Neuroleptic dysphoria \u2014 towards new synthesis","volume":"171","author":"Voruganti","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2006.07.012_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/070674370404900502","article-title":"Is neuroleptic dysphoria a variant of extrapyramidal side effects?","volume":"49","author":"Voruganti","year":"2004","journal-title":"Can. J. Psychiatry"},{"issue":"Suppl 427","key":"10.1016\/j.schres.2006.07.012_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0447.2005.00541.x","article-title":"Brain imaging research on subjective response to psychotropic drugs","author":"Voruganti","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2006.07.012_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005053-199707000-00008","article-title":"Neuroleptic dysphria may be the missing link between schizophrenia and substance abuse","volume":"185","author":"Voruganti","year":"1997","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2006.07.012_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0920-9964(99)00154-1","article-title":"Comparative evaluation of conventional and new antipsychotic drugs with reference to their subjective tolerability, side effect profile and impact on quality of life","volume":"43","author":"Voruganti","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2006.07.012_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0893-133X(01)00263-9","article-title":"Subjective effects of AMPT induced dopamine depletion in schizophrenia: correlation between dysphoria response and striatal D2 binding ratios and SOPECTS imaging","volume":"25","author":"Voruganti","year":"2001","journal-title":"Neuropsychopharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996406003148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996406003148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T01:20:37Z","timestamp":1555809637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996406003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":34,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0920996406003148"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2006.07.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}